Vyvanse 30MG cap 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FAZDE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,281
Award facts
- Contract value 100% obligated
- $16,281.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on May 6, 2026, for Vyvanse 30 mg capsules (100-count bottles) with a ceiling value of $16,281.12.
Place of performance is Conshohocken, PA. The order carries an ultimate completion date of May 7, 2026, and is priced on a firm fixed-price basis. No set-aside was applied.
Quick answers
Who was awarded contract SPE2DR26FAZDE?
SPE2DR26FAZDE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 6, 2026.
How much is contract SPE2DR26FAZDE worth?
The government has obligated $16,281 on SPE2DR26FAZDE.
Is contract SPE2DR26FAZDE an order under another contract?
Yes. SPE2DR26FAZDE is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAZDE competed?
The extent of competition for SPE2DR26FAZDE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award